广东东阳光科技控股股份有限公司关于控股股东之一致行动人部分股份解质押及质押的公告

Core Viewpoint - The announcement details the share pledge and unpledge activities of the controlling shareholder and its concerted action party, indicating a significant portion of shares are pledged but does not pose a risk to the company's operations or governance [2][6]. Group 1: Shareholding and Pledge Details - Yichang Dongyangguang Pharmaceutical Co., Ltd. holds 545,023,350 shares, accounting for 18.11% of the total share capital, with 489,650,000 shares pledged, representing 89.84% of its holdings [2]. - Shenzhen Dongyangguang Industrial Development Co., Ltd. has pledged 541,527,254 shares, which is 87.37% of its holdings, while the total pledged shares by the controlling shareholder and its concerted action parties amount to 1,212,267,797 shares, or 76.23% of their combined holdings [2][5]. Group 2: Pledge and Unpledge Activities - The recent unpledging of shares by Yichang Pharmaceutical is intended for subsequent pledging, indicating a strategic financial maneuver [3]. - The pledged shares are not used as collateral for major asset restructuring or performance compensation, ensuring no immediate risk to the company's financial stability [4][6]. Group 3: Financial Impact and Risk Assessment - The financial health of Shenzhen Dongyangguang Industrial and Yichang Pharmaceutical is stable, with sufficient repayment sources from operational income and investment returns [6]. - The share pledging activities will not affect the company's operations, financing costs, or governance structure, and there are no current risks of forced liquidation or changes in control [6].